Here are five more findings and statistics from the survey.
1. Forty-nine percent of respondents said precision medicine has a positive impact on patient volume today, and 53 percent said they expect to see this in two years.
2. Thirty-eight percent of respondents said it has a positive impact on drug and treatment discovery today, and 46 percent expect to see this in two years.
3. Healthcare organizations are starting preparations for high-level privacy and security changes to accommodate precision medicine programs: 64 percent have changed their privacy policies, 60 percent have increased the security of patient data and 47 percent are changing organizational culture to reflect these privacy and security changes.
4. Respondents identified the following technologies as being necessary to precision medicine: big data capture and storage, collaboration tools, predictive analytics and decision support tools.
5. Healthcare organizations are mainly prioritizing their precision medicine work around diabetes (45 percent). Other illnesses and conditions include common cancers (38 percent), neurological diseases (33 percent), cardiovascular conditions (28 percent), aging (24 percent), autoimmune diseases (20 percent), rare or orphan cancers (12 percent) and other orphan diseases (8 percent).
More articles on precision medicine:
New technology eases adoption of precision medicine initiative
7 genome sequencing, biobank projects in the news
VA’s Million Veteran Program to aid federal Precision Medicine Initiative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
